Acute complication due to impella 2.5 device (superficial femoral artery thrombosis): managed successfully with novel aspiration thrombectomy catheter (pronto v3)
- PMID: 21344022
- PMCID: PMC3041237
- DOI: 10.4137/CMC.S6157
Acute complication due to impella 2.5 device (superficial femoral artery thrombosis): managed successfully with novel aspiration thrombectomy catheter (pronto v3)
Abstract
The Impella recover LP 2.5 is a percutaneous left ventricular assist device (LVAD) recently approved for use in patients undergoing high risk percutaneous coronary intervention (PCI) and also in cases of cardiogenic shock. There is limited evidence available in literature about its safety, especially with regards to the incidence of local vascular complications, their management and long-term implications. We report here the first case of a serious local vascular complication-superficial femoral artery thrombus formation during Impella recover LP 2.5 use in a high risk PCI which was managed successfully with novel aspiration thrombectomy catheter (Pronto V3), which in itself is the first reported use of Pronto V3 in such a vascular complication.
Keywords: complication of impella; high risk PCI; impella LP 2.5; pronto V3.
Figures
Similar articles
-
Percutaneous Ventricular Assist Devices: A Health Technology Assessment.Ont Health Technol Assess Ser. 2017 Feb 7;17(2):1-97. eCollection 2017. Ont Health Technol Assess Ser. 2017. PMID: 28232854 Free PMC article. Review.
-
Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.Minerva Cardioangiol. 2008 Aug;56(4):391-9. Minerva Cardioangiol. 2008. PMID: 18614983
-
Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.Eur Heart J Acute Cardiovasc Care. 2017 Feb;6(1):87-92. doi: 10.1177/2048872616633877. Epub 2016 Sep 20. Eur Heart J Acute Cardiovasc Care. 2017. PMID: 26873912
-
Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?Cardiovasc Revasc Med. 2010 Apr-Jun;11(2):91-7. doi: 10.1016/j.carrev.2009.07.006. Cardiovasc Revasc Med. 2010. PMID: 20347798
-
Acute mitral regurgitation: unforeseen new complication of the Impella LP 5.0 ventricular assist device and review of literature.Heart Lung Circ. 2014 Mar;23(3):e100-4. doi: 10.1016/j.hlc.2013.10.098. Epub 2013 Nov 15. Heart Lung Circ. 2014. PMID: 24296306 Review.
Cited by
-
Percutaneous thrombectomy of Impella-associated iliac artery thrombosis using the FlowTriever system.Clin Case Rep. 2020 Aug 18;8(12):2645-2649. doi: 10.1002/ccr3.3226. eCollection 2020 Dec. Clin Case Rep. 2020. PMID: 33363797 Free PMC article.
-
Lower extremity artery thromboembolism during removal of Impella after repair for ventricular septal rupture: A case report.SAGE Open Med Case Rep. 2024 Jun 14;12:2050313X241260228. doi: 10.1177/2050313X241260228. eCollection 2024. SAGE Open Med Case Rep. 2024. PMID: 38881970 Free PMC article.
References
-
- Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention. Catheter Cardiovasc Interv. 2005;65(2):263–7. - PubMed
-
- Meyns B, Dens J, Sergeant P, Herijgers P, Daenen W, Flameng W. Initial experiences with the Impella device in patients with cardiogenic shock—Impella support for cardiogenic shock. Thorac Cardiovac Surg. 2003;51(6):312–7. - PubMed
-
- Sauren LD, Accord RE, Hamzeh K, et al. Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study. Artif Organs. 2007;31(11):839–42. - PubMed
-
- Toggweiler S, Jamshidi P, Erne P. Functional mitral stenosis: a rare complication of the Impella assist device. Eur J Echocardiogr. 2008 - PubMed
-
- Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial US experience. JACC Cardiovasc Interv. 2009;2(2):91–6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous